PomDoctor Limited (POM)
PomDoctor will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
5,000,004
Deal Size
$25.00M
Company Description
Pomdoctor is a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022.
With focuses on chronic disease management and pharmaceutical services, our business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products.
PomDoctor Limited
| Country | China |
| Founded | 2015 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 154 |
| CEO | Zhenyang Shi |
Contact Details
Address: Yongxu Industrial Park, No.19-23 Hejing Road, Dongsha Street Liwan District, Guangzhou 510000 China | |
| Phone | +86 020-6231 2277 |
| Website | 7lk.com |
Stock Details
| Ticker Symbol | POM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| CIK Code | 0001877971 |
| SIC Code | 5900 |
Key Executives
| Name | Position |
|---|---|
| Zhenyang Shi | Chairman, Chief Executive Officer |
| Li Xu | Chief Financial Officer |
| Guoji Luo | Vice President, Director Appointee |
| Dexiang Wei | Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 15, 2025 | 8-A12B | Registration of securities |
| Jul 15, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jun 17, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| May 14, 2025 | F-6 | Filing |
| Mar 31, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Mar 13, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Jan 17, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Dec 23, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 6, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| May 2, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |